Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40760410	b-hlabdt	— (—)	183	185	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Primary_lymphoid and hematopoietic malignant neoplasms

126

84.92

238.48

1.0

—

Transplanted organ and tissue status

103

105.49

199.79

1.0

—

Liquid cancers, including Hilmo

164

243.91

152.71

1.0

—

Liquid cancers

156

249.08

149.26

1.0

1.2

—

Malignant neoplasm, including Hilmo

124

60.28

138.41

1.0

—

Malignant neoplasm

121

41.76

128.72

1.0

1.1

—

Malignant neoplasm

121

41.76

128.71

1.0

1.1

—

Malignant neoplasm, wide definition

118

40.47

124.18

1.0

1.1

—

L04AD Calcineurin inhibitors

49.77

101.80

1.0

—

Any event in cancer register

108

24.29

101.72

1.0

—

ILD medications: immunosuppressive drugs

14.36

99.25

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

115

12.33

88.43

1.0

—

Other diseases of blood and blood-forming organs, wide

26.96

86.27

1.0

—

Fever of other and unknown origin

13.34

81.10

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

108

10.71

80.12

1.0

—

Acute myeloid leukaemia and myelodysplastic syndromes

+∞

67.49

1.0

0.0

—

Bacterial infection, other or unspecified

13.16

63.98

1.0

—

Other bacterial diseases

8.52

62.85

1.0

—

Bacterial infection, other or unspecified, including avohilmo

11.87

60.20

1.0

—

Other bacterial diseases, including avohilmo

7.95

57.34

1.0

—

Septicaemia

14.27

52.22

1.0

—

ILD medications

8.13

50.32

1.0

—

Other septicaemia, including avohilmo

14.91

50.02

1.0

—

Acute myeloid leukaemia, including Hilmo

+∞

49.81

1.0

0.0

—

Acute myeloid leukaemia

+∞

49.81

1.0

0.0

—

Acute myeloid leukaemia, helper endpoint

+∞

49.81

1.0

0.0

—

Aplastic and other anaemias

10.69

49.41

1.0

—

Other septicaemia

14.17

47.75

1.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

61.87

47.33

1.0

—

Explicit Sepsis, including avohilmo

10.52

44.30

1.0

—

Explicit Sepsis

10.13

42.46

1.0

—

Neoplasms

42.67

42.18

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.21

41.17

1.0

—

Dental caries

12.61

39.72

1.0

—

Caries of dentine

13.75

39.08

1.0

—

Complications of medical and surgical care

6.38

38.45

1.0

—

Other and unspecified anaemias

9.40

38.45

1.0

—

First line medication for Crohn's disease

6.47

38.41

1.0

—

Other anaemias

9.37

38.31

1.0

—

Solid cancers, including Hilmo

15.43

36.33

1.0

1.1

—

Anaemias

+∞

35.67

1.0

0.0

—

Solid cancers

16.42

34.90

1.0

1.1

—

Any gastric operation

15.72

34.29

1.0

—

GASTRO-related operations

15.72

34.29

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

6.38

32.62

1.0

—

Complications of surgical and medical care, not elsewhere classified

5.00

29.19

1.0

—

Influenza and pneumonia

104

4.63

28.13

1.0

—

Coagulation defects, purpura and other haemorrhagic conditions

10.36

27.98

1.0

—

Agranulocytosis

28.66

27.55

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5.85

26.23

1.0

—

5.85

26.23

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

107

4.33

24.36

1.0

—

All pneumoniae

110

4.25

24.11

1.0

—

Certain infectious and parasitic diseases

6.29

23.62

1.0

—

Myeloproliferative diseases

36.54

22.98

1.0

—

Myelodysplastic syndrome

+∞

22.04

1.0

0.0

—

General examination and investigation of persons without complaint and reported diagnosis

6.88

21.54

1.0

—

General symptoms and signs

4.78

21.51

1.0

—

Oxycodone

6.29

20.35

1.0

—

Pneumonia, organism unspecified

100

4.11

19.77

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

115

3.82

19.57

1.0

—

Infections, IBD-co-morbidities

8.58

18.52

1.0

—

Myeloproliferative diseases (CML excluded)

30.22

18.32

1.0

—

Purpura and other haemorrhagic conditions

17.57

18.20

1.0

—

Other medical care

5.32

18.10

1.1

1.0

—

Multiple myeloma, including Hilmo

+∞

17.73

1.0

0.0

—

COPD/asthma/ILD related infections

4.59

17.71

1.0

—

COPD/asthma related infections

4.59

17.71

1.0

—

Any reimbursement code in KELA

29.07

17.53

1.0

1.2

—

Non-Hodgkin lymphoma, all

+∞

16.69

1.0

0.0

—

Thrombocytopenia, unspecified

40.29

16.32

1.1

1.0

—

Medical observation and evaluation for suspected diseases and conditions

5.71

15.59

1.0

—

Abnormal findings on diagnostic imaging of lung

5.07

14.67

1.0

—

Lymphoid leukaemia

22.40

14.21

1.0

—

Covid-19 confirmed case

5.18

13.84

1.0

—

Multiple myeloma and malignant plasma cell neoplasms

34.28

13.50

1.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

10.46

13.20

1.0

—

Other metabolic disorders

10.45

13.20

1.0

—

Provisional assignment of new diseases of uncertain etiology

4.13

13.19

1.0

—

Codes for special purposes

4.13

13.18

1.0

—

Polycythaemia vera

+∞

12.52

1.0

0.0

—

Any death

3.97

12.17

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

3.46

12.11

1.0

—

Bronchitis

112

3.05

11.93

1.0

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

130

3.05

11.57

1.0

—

Enlarged lymph nodes

13.60

11.43

1.0

—

Viral infections characterized by skin and mucous membrane lesions

3.90

11.23

1.0

—

L04AA Selective immunosuppressants

5.25

11.04

1.0

—

3.12

10.87

1.0

—

COPD differential diagnosis

4.20

10.84

1.0

—

ILD differential diagnosis

4.20

10.84

1.0

—

Excluding asthma or asthma-COPD overlap

4.20

10.84

1.0

—

Other pulmonary diagnosis

4.20

10.84

1.0

—

Acute upper respiratory infections

100

3.06

10.73

1.0

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

+∞

10.43

1.0

0.0

—

Multiple myeloma

+∞

10.43

1.0

0.0

—

Certain infectious and parasitic diseases, including avohilmo

5.20

10.15

1.0

—

Non-follicular lymphoma

13.13

10.14

1.0

—

Inflammatory bowel disease treatment related agents

116

2.77

10.13

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3.33

9.73

1.0

—

Other acute lower respiratory infections

3.54

9.71

1.0

—

Other viral diseases

4.27

9.51

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

122

3.02

9.19

1.0

—

Drug-induced neutropenia

13.70

9.17

1.0

—

Other viral diseases, including avohilmo

3.65

8.98

1.0

—

Zoster [herpes zoster], including avohilmo

3.65

8.93

1.0

—

Bacterial Sepsis

4.32

8.73

1.1

1.0

—

Acute sinusitis

3.45

8.68

1.0

—

L01XE Protein kinase inhibitors

16.35

8.55

1.0

—

Acute bronchitis

3.92

8.50

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

4.17

8.47

1.0

—

Malignant neoplasm of skin, including Hilmo

14.35

8.46

1.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

15.74

8.19

1.0

1.2

—

Other diseases of blood and blood-forming organs

17.21

8.07

1.0

—

Second line medication for Crohn's disease

109

3.03

7.95

1.0

—

Oral corticosteroids

109

2.58

7.58

1.0

—

L04AX Other immunosuppressants

107

2.99

7.57

1.0

—

Persons encountering health services for specific procedures and health care

125

2.45

7.46

1.0

—

Diffuse large B-cell lymphoma, including Hilmo

+∞

7.29

1.0

0.0

—

Diffuse large B-cell lymphoma, helper endpoint

+∞

7.29

1.0

0.0

—

Diffuse large B-cell lymphoma

+∞

7.29

1.0

0.0

—

Bacterial pneumonia (organism specified)

3.51

7.14

1.0

—

Mycoses

4.05

7.06

1.0

—

DVT of lower extremities and pulmonary embolism

3.74

7.01

1.0

—

Enterocolitis due to Clostridium difficile

13.78

6.88

1.0

—

Malignant neoplasm of skin

13.53

6.74

1.0

1.2

—

Other and unspecified dermatitis

3.03

6.59

1.0

—

Certain disorders involving the immune mechanism

5.46

6.59

1.0

—

Hypothyroidism and >3 levothyroxin purchases

+∞

6.56

1.0

0.0

—

Hypothyroidism, levothyroxine purchases

+∞

6.56

1.0

0.0

—

Hypothyroidism (congenital or acquired)

+∞

6.56

1.0

0.0

—

Viral pneumonia

8.68

6.54

1.0

—

Diseases of the respiratory system

3.76

6.44

1.0

—

Malignant neoplasm of digestive organs, including Hilmo

13.48

6.35

1.0

1.2

—

Zoster [herpes zoster]

5.93

6.29

1.0

—

Bacterial pneumoniae

3.95

6.27

1.1

1.0

—

Mantle cell lymphoma, including Hilmo

+∞

6.26

1.0

0.0

—

Implicit bacterial Sepsis

3.96

6.24

1.1

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

12.44

6.04

1.0

1.2

—

Examination and observation for other reasons

3.65

5.98

1.0

—

Gout, FINNGEN

4.83

5.68

1.0

—

All influenza

5.16

5.68

1.0

—

Dermatitis

107

2.65

5.57

1.0

—

Metabolic disorders

120

2.25

5.48

1.0

—

Persons encountering health services for examination and investigation

3.39

5.44

1.0

—

Implicit bacterial Sepsis, including avohilmo

3.56

5.40

1.1

1.0

—

Venous thromboembolism

2.89

5.39

1.0

—

Asthma, excluding more controls

3.13

5.33

1.0

—

Basal cell carcinoma, including Hilmo

11.28

5.32

1.0

1.2

—

Haemophagocytic lymphohistiocytosis

+∞

5.29

1.0

0.0

—

All kidney diseases

134

2.20

5.25

1.0

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

+∞

5.24

1.0

0.0

—

Chronic myeloid leukaemia, including Hilmo

+∞

5.22

1.0

0.0

—

Mantle cell lymphoma

+∞

5.22

1.0

0.0

—

Other bacterial intestinal infections

5.39

5.21

1.0

—

Other disorders of lacrimal gland

3.13

5.18

1.0

—

Gout

3.56

5.14

1.0

—

Pulmonary embolism

3.75

5.08

1.1

1.0

—

Pulmonary heart disease

3.75

5.08

1.1

1.0

—

Bacterial intestinal infections, IBD co-morbidities

5.19

5.07

1.0

—

Asthma

3.00

5.01

1.0

—

Asthma (only as main-diagnosis), excluding more controls

3.10

4.98

1.0

—

Diseases of the skin and subcutaneous tissue

2.29

4.96

1.0

—

Other skin changes

5.01

4.93

1.0

—

Gastrointestinal diseases

3.29

4.79

1.0

—

Family history of malignant neoplasm

11.44

4.78

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.85

4.75

1.0

—

Asthma (only as main-diagnosis)

2.99

4.73

1.0

—

Procreative management

2.79

4.70

1.0

—

Herpesviral [herpes simplex] infections

6.12

4.60

1.0

—

6-mercaptopurine

14.05

4.57

1.0

—

Other bacterial intestinal infections, including avohilmo

4.52

4.54

1.0

—

Herpesviral [herpes simplex] infections, including avohilmo

3.34

4.31

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

3.33

4.31

1.1

1.0

—

Malignant neoplasm of digestive organs

10.19

4.30

1.0

1.2

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

11.71

4.27

1.0

—

Implicit fungal Sepsis, including avohilmo

11.69

4.27

1.0

—

Bacterial pneumonia, not elsewhere classified

3.38

4.26

1.0

—

Asthma (mode)

2.81

4.22

1.0

—

Headache

2.75

4.15

1.0

—

Recurrent aphthous stomatitis , including avohilmo

5.24

4.13

1.0

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

10.05

4.01

1.0

—

Other disorders involving the immune mechanism, not elsewhere classified

10.05

4.01

1.0

—

Follicular lymphoma, hilmo

10.04

4.01

1.0

—

Basal cell carcinoma

9.09

3.98

1.0

1.2

—

Rash and other nonspecific skin eruption

6.44

3.98

1.0

—

Endocrine, nutritional and metabolic diseases

2.16

3.92

1.0

—

Depression medications

+∞

3.90

1.0

0.0

—

Opioids

2.19

3.86

1.0

—

Other infectious diseases, including avohilmo

7.29

3.85

1.0

—

Stomatitis and related lesions

3.69

3.78

1.0

—

Intestinal infectious diseases

142

1.99

3.70

1.0

—

Other infectious diseases

7.79

3.56

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.81

3.51

1.0

—

Asthma, unspecified (mode), excluding more controls

2.93

3.49

1.0

—

Codeine

2.15

3.42

1.0

—

Disorders of lacrimal system

2.46

3.41

1.0

—

Budesonide

4.35

3.30

1.0

—

Asthma, unspecified (mode)

2.82

3.28

1.0

—

Viral pneumonia (known virus, not influenza)

8.61

3.26

1.0

—

Other complications of surgical and medical care, not elsewhere classified

8.58

3.26

1.0

—

Other heart diseases

2.38

3.22

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

2.18

3.14

1.0

—

Streptococcal septicaemia

7.51

3.05

1.2

1.0

—

Streptococcal septicaemia, including avohilmo

7.51

3.05

1.2

1.0

—

Misadventures to patients during surgical and medical care

5.84

3.02

1.1

1.0

—

Other and unspecified disorders of white blood cells

10.03

2.98

1.0

—

Benign neoplasms

103

1.90

2.95

1.0

—

Finngen Rheumatological endpoints

113

1.86

2.87

1.0

—

Viral pneumonia (unknown virus, not influenza)

6.68

2.87

1.0

—

Renal tubulo-interstitial diseases

128

1.89

2.84

1.0

—

Dermatitis and eczema

136

1.78

2.84

1.0

—

Renal failure

2.45

2.84

1.1

1.0

—

Polyarthropathies

2.02

2.83

1.0

—

Protozoal diseases

8.36

2.75

1.0

—

Protozoal diseases, including avohilmo

8.36

2.75

1.0

—

Other disorders of white blood cells

8.35

2.75

1.0

—

Other reaction to severe stress, and adjustment disorders

2.31

2.73

1.0

—

Pain, not elsewhere classified

3.45

2.68

1.0

—

Other heart diseases, wide

129

1.78

2.66

1.0

—

Other abnormal findings of blood chemistry

7.16

2.55

1.0

—

Other noninfective gastroenteritis and colitis

2.73

2.54

1.0

—

Oedema, not elsewhere classified

3.26

2.53

1.0

—

Pain (limb, back, neck, head abdominally)

1.99

2.49

1.0

—

Implicit Sepsis

2.04

2.48

1.0

—

Haemorrhagic and haematological disorders of fetus and newborn

6.86

2.47

1.0

—

External causes of morbidity and mortality

2.19

2.45

1.0

—

Cardiovascular diseases

2.05

2.44

1.0

—

ILD medications: azathioprine

5.00

2.40

1.0

—

Parasetamol

2.01

2.37

1.0

—

Other embolism and thrombosis

4.12

2.36

1.0

—

Other problems related to primary support group, including family circumstances

3.54

2.29

1.0

—

Symptoms and signs involving the digestive system and abdomen

115

1.70

2.27

1.0

—

Other Crohn's disease

4.62

2.27

1.0

—

Explicit bacterial Sepsis

4.62

2.27

1.2

1.0

—

Explicit bacterial Sepsis, including avohilmo

4.62

2.27

1.2

1.0

—

Nausea and vomiting

2.75

2.26

1.0

—

Pruritus

3.89

2.25

1.0

—

Crohn disease

3.89

2.25

1.0

—

Unspecified acute lower respiratory infection

3.11

2.22

1.0

—

Other pleural conditions

5.56

2.21

1.0

—

Personal history of other diseases and conditions

5.53

2.20

1.0

—

Mycoses, including avohilmo

147

1.71

2.15

1.0

—

Injury, poisoning and certain other consequences of external causes

2.20

2.14

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

2.78

2.13

1.1

1.0

—

Erysipelas

2.38

2.09

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

127

1.69

2.08

1.0

—

Urticaria and erythema

2.13

2.07

1.0

—

Osteonecrosis

5.01

2.07

1.0

—

Caries of enamel

137

1.67

2.06

1.0

—

Noninfectious colitis NAS

3.50

2.05

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2.42

2.05

1.0

—

Certain conditions originating in the perinatal period

4.10

2.04

1.0

—

Erysipelas, including avohilmo

2.10

2.01

1.0

—

Hypertensive diseases (excluding secondary)

2.01

2.00

1.0

—

Diseases of the ear and mastoid process

124

1.62

1.98

1.0

—

Osteopathies and chondropathies

1.92

1.97

1.0

—

Bacterial, viral and other infectious agents

3.75

1.93

1.0

—

Bacterial, viral and other infectious agents, including avohilmo

3.75

1.93

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

125

1.61

1.91

1.0

—

Persons encountering health services in circumstances related to reproduction

109

1.72

1.87

1.0

—

Abnormal findings on examination of blood, without diagnosis

2.00

1.86

1.0

—

Candidiasis, including avohilmo

2.39

1.85

1.0

—

Use of hypnotics and sedatives

132

1.60

1.84

1.0

—

Acute pharyngitis

2.83

1.83

1.0

—

Allergic asthma (mode)

3.11

1.83

1.0

—

Allergic asthma (mode), excluding more controls

3.11

1.83

1.0

—

Asthma-related pneumonia

2.20

1.82

1.0

—

Asthma, hospital admissions 3, pneumonia

2.20

1.82

1.0

—

Asthma-related pneumonia or sepsis

2.20

1.82

1.0

—

Undetermined asthma

4.17

1.82

1.0

—

Undetermined asthma, excluding more controls

4.16

1.82

1.0

—

Acute tubulo-interstitial nephritis

1.91

1.82

1.0

—

Persons encountering health services in other circumstances

2.00

1.80

1.0

—

Candidiasis

3.05

1.79

1.0

—

Chronic diseases of tonsils and adenoids

118

1.66

1.79

1.0

—

Noninfective enteritis and colitis

1.91

1.79

1.0

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

3.03

1.78

1.0

—

Exposure to other specified factors

151

1.65

1.75

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2.51

1.72

1.0

—

Implicit Sepsis, including avohilmo

1.77

1.71

1.0

—

Complications of procedures, not elsewhere classified

1.80

1.69

1.0

—

Other diseases of lip and oral mucosa

2.00

1.69

1.0

—

Sarcoidosis

2.80

1.65

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

104

1.69

1.64

1.0

—

Abdominal and pelvic pain

115

1.57

1.64

1.0

—

Viral warts, including avohilmo

2.44

1.64

1.0

—

Melanocytic naevi of trunk

3.57

1.61

1.0

—

Hypopituitarism

3.57

1.61

1.0

—

Intestinal infectious diseases, including avohilmo, including avohilmo

134

1.54

1.58

1.0

—

Cellulitis

2.33

1.58

1.0

—

Nephropathy related operations

3.00

1.58

1.0

—

Early onset COPD, excluding more controls

3.00

1.58

1.0

—

Heart failure, not strict

105

1.66

1.58

1.0

—

Presence of other functional implants

2.28

1.57

1.0

—

Urolithiasis

2.20

1.56

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

122

1.68

1.53

1.0

—

Chronic kidney disease

2.24

1.52

1.1

1.0

—

Eustachian salpingitis and obstruction

3.34

1.52

1.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

3.34

1.52

1.2

1.0

—

All chronic kidney diseases

1.86

1.52

1.1

1.0

—

Benzodiazepine use

144

1.55

1.51

1.0

—

Pollen allergy

0.00

1.51

0.0

1.0

—

Glomerular diseases

2.59

1.51

1.0

—

DVT of lower extremities

2.59

1.51

1.0

—

Pacemaker

0.00

1.50

0.0

1.0

—

Dialysis, with operation codes

2.86

1.50

1.0

—

Congenital malformations and deformations of the musculoskeletal system

2.84

1.49

1.0

—

Other disorders of skin and subcutaneous tissue

116

1.67

1.49

1.0

—

Other disorders of ear

128

1.56

1.49

1.0

—

Glomerulonephritis

3.13

1.44

1.0

—

LSIL lesion of the cervix uteri

2.73

1.43

1.0

—

Dysplasia of cervi uteri

2.34

1.43

1.0

—

Covid-19 suspected case

2.31

1.42

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.66

1.41

1.0

—

Chronic apical periodontitis

121

1.53

1.41

1.0

—

Non-ischemic cardiomyopathy

2.13

1.40

1.0

—

Sequelae of external causes of morbidity and mortality

2.17

1.39

1.0

—

Infections of the skin and subcutaneous tissue

124

1.67

1.39

1.0

—

Nerve, nerve root and plexus disorders

131

1.51

1.37

1.0

—

Status post-ami

0.00

1.37

0.0

1.0

—

Neurotic, stress-related and somatoform disorders

135

1.53

1.35

1.0

—

Haemorrhage from respiratory passages

2.07

1.35

1.0

—

Acute appendicitis, with complications

0.00

1.34

0.0

1.0

—

Spondylolisthesis/Spondylolysis

0.00

1.33

0.0

1.0

—

Other diseases of anus and rectum

2.14

1.33

1.0

—

Anxiety disorders

135

1.52

1.33

1.0

—

Persons encountering health services in other circumstances, wide

125

1.48

1.32

1.0

—

Disease of hard tissues of teeth, NOS

2.00

1.31

1.0

—

Pediculosis, acariasis and other infestations, including avohilmo

0.00

1.31

0.0

1.0

—

Sequelae with surgical and medical care as external cause

2.35

1.29

1.0

—

Major coronary heart disease event excluding revascularizations

0.42

1.29

1.0

—

All dysplastic lesions of the cervix uteri

2.06

1.27

1.0

—

Acute renal failure

2.29

1.26

1.1

1.0

—

Implicit viral Sepsis, including avohilmo

2.28

1.26

1.0

—

Codeine or tramadol medication

125

1.48

1.26

1.0

—

Disorders of eyelid, lacrimal system and orbit

129

1.53

1.25

1.0

—

Disorders of other endocrine glands

1.78

1.25

1.0

—

Fracture of lower leg, including ankle

114

0.43

1.24

1.2

1.0

—

Other symptoms and signs involving the digestive system and abdomen

2.40

1.24

1.0

—

Sleep disorders

149

0.55

1.22

1.0

—

Calculus of kidney and ureter

2.04

1.21

1.0

—

Chronic laryngitis and laryngotracheitis

2.63

1.21

1.0

1.1

—

Conductive and sensorineural hearing loss

102

1.56

1.19

1.0

—

Abnormalities of breathing

115

1.49

1.19

1.0

—

Antihypertensive medication - note that there are other indications

1.64

1.19

1.0

—

LSIL lesion of the cervix uteri, vagina or vulva

2.31

1.18

1.0

—

Diseases of oral cavity, salivary glands and jaws

1.91

1.18

1.0

—

Coronary artery bypass grafting

0.00

1.17

0.0

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.13

1.17

1.1

1.0

—

Alcohol use disorder, Swedish definition

118

0.46

1.16

1.0

—

Scabies, including avohilmo

0.00

1.16

0.0

1.0

—

Autoimmune diseases related-to ILD

144

1.51

1.16

1.0

—

Tramadol

1.62

1.14

1.0

—

Ischemic heart diseases

126

0.57

1.13

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

151

0.58

1.12

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

2.04

1.12

1.0

—

Asthma (diagnoses ohter than nonallergic)

147

1.48

1.12

1.0

—

Impacted teeth

2.31

1.11

1.0

—

Sensorineural hearing loss

1.55

1.11

1.0

—

Diseases of male genital organs

1.62

1.10

1.0

—

Complications of labour and delivery

0.48

1.10

1.0

—

Sleep disorders (combined)

142

0.62

1.09

1.0

—

Major coronary heart disease event

125

0.57

1.09

1.0

—

Other diseases of pleura

1.83

1.08

1.0

—

Diseases of external ear

1.86

1.07

1.0

—

Emergency coronary revascularization (for ACS)

125

0.58

1.06

1.0

—

Open wound of head

116

0.49

1.05

1.0

—

Medical treatment for female infertility

2.10

1.04

1.0

—

Heart failure and antihypertensive medication

1.97

1.04

1.0

—

Genitourinary diseases

1.57

1.03

1.0

—

2.27

1.03

1.2

1.0

—

Abnormal findings on diagnostic imaging of other body structures

2.27

1.03

1.0

—

Biguanides

139

0.61

1.03

1.0

—

Other (not insulin) diabetes medications

135

0.61

1.03

1.0

—

Melanocytic naevi

1.83

1.02

1.0

—

Sulfasalazine

1.92

1.02

1.0

—

Malaise and fatigue

1.92

1.01

1.0

—

Endometriosis of pelvic peritoneum

0.00

0.98

0.0

1.0

—

Other disorders of breast

2.17

0.98

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

0.98

0.0

1.0

—

Operations 2 for CAVS

0.00

0.98

0.0

1.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

0.98

0.0

1.0

—

Calcific aortic valvular stenosis, operated

0.00

0.98

0.0

1.0

—

Calcific aortic valvular stenosis

0.00

0.98

0.0

1.0

—

Other blood glucose lowering drugs, excl. Insulins

0.00

0.97

0.0

1.0

—

Coxarthrosis

1.67

0.97

1.0

—

Other viral diseases, not elsewhere classified

1.94

0.96

1.0

—

Other/unspecified dorsalgia

1.74

0.96

1.0

—

Endometriosis ASRM stages 1,2

0.00

0.96

0.0

1.0

—

Other viral diseases, not elsewhere classified, including avohilmo

1.84

0.94

1.0

—

Insomnia

147

0.61

0.94

1.0

—

Other inflammation of eyelid, including avohilmo

1.61

0.93

1.0

—

Azathioprine

2.22

0.93

1.0

—

Benign neoplasm of other and ill-defined parts of digestive system

2.22

0.93

1.0

—

Pain in limb

120

1.43

0.93

1.0

—

Other diseases of hard tissues of teeth

1.78

0.91

1.0

—

Hypothyroidism, strict autoimmune

1.50

0.91

1.0

—

Coronary revascularization (ANGIO or CABG)

120

0.61

0.91

1.0

—

Percutaneous Coronary Intervention

120

0.61

0.91

1.0

—

Disorders of lens

1.48

0.90

1.0

—

Asthma, hospital admissions , main diagnosis only

145

1.44

0.90

1.0

—

Asthma-related infections

115

1.53

0.90

1.0

—

Asthma, hospital admission 2, infections

115

1.53

0.90

1.0

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

101

0.49

0.89

1.0

—

Anxiety disorders, excluding more controls

122

1.41

0.89

1.0

—

Excessive earwax

116

0.55

0.88

1.0

—

Diagnoses used for exclusion with ILD

1.91

0.88

1.0

—

Injuries to the head

159

0.67

0.88

1.0

—

Coxarthrosis, primary

1.60

0.88

1.0

—

Dental pulpitis, including avohilmo

156

0.66

0.88

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

101

1.46

0.87

1.0

—

Polyuria

2.00

0.87

1.0

—

Coxarthrosis [arthrosis of hip](FG)

1.57

0.86

1.0

—

Hypertensive diseases

108

1.41

0.86

1.0

—

Hypertension

108

1.41

0.86

1.0

—

Unspecified haematuria

1.68

0.85

1.0

—

Contraceptive management

0.52

0.85

1.0

—

Stroke, including SAH

0.53

0.85

1.0

—

Other diseases of upper respiratory tract

122

1.37

0.85

1.0

—

Hypertension, essential

104

1.41

0.84

1.0

—

Ischaemic heart disease, wide definition

111

0.61

0.83

1.0

—

Other diseases of intestines

136

1.35

0.83

1.0

—

Hard cardiovascular diseases

128

0.65

0.83

1.0

—

Coxarthrosis, primary, with hip surgery

1.70

0.82

1.0

—

Fenamates

0.00

0.81

0.0

1.0

—

Other obstetric conditions, not elsewhere classified

1.74

0.81

1.0

—

Disorders of gallbladder, biliary tract and pancreas

132

1.37

0.80

1.0

—

Later onset COPD

0.00

0.80

0.0

1.0

—

Multiple delivery

0.00

0.79

0.0

1.0

—

Restless leg syndrome

0.00

0.79

0.0

1.0

—

Pain in thoracic spine

1.82

0.79

1.0

—

Chronic gastritis

1.82

0.79

1.0

—

Rosacea

0.00

0.79

0.0

1.0

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

134

1.43

0.78

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

125

1.35

0.78

1.0

—

Used for control exclusion in common control thyroid runs

120

1.34

0.78

1.0

—

Depression or dysthymia

0.61

0.77

1.0

—

Other disorders of conjunctiva

0.00

0.77

0.0

1.0

—

Assault

0.00

0.77

0.0

1.0

—

Nontoxic multinodular goitre

0.00

0.77

0.0

1.0

—

Other headache syndromes

1.55

0.77

1.0

—

Exclusions for E4_PCOS_BROAD

1.76

0.76

1.0

—

COPD (mode)

2.17

0.76

1.0

—

Gastroduodenal ulcer

1.76

0.76

1.0

—

Other soft tissue disorders, not elsewhere classified

122

1.35

0.75

1.0

—

Noninflammatory disorders of female genital tract

1.67

0.75

1.0

—

Chronic lower respiratory diseases

145

1.31

0.74

1.0

—

Convulsions, not elsewhere classified

2.06

0.74

1.0

—

Substance abuse

126

0.59

0.73

1.0

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.63

0.73

1.0

—

Anomalies of dental arch relationship, including avohilmo

1.81

0.72

1.0

—

Implicit viral Sepsis

2.00

0.72

1.0

—

Viral Sepsis

2.00

0.72

1.0

—

Other disorders of bone

1.75

0.71

1.0

—

Autoimmune diseases excluding thyroid diseases

127

1.32

0.70

1.0

—

Other/unspecified synovitis and tenosynovitis

1.92

0.70

1.0

—

Spondyloarthritis

1.92

0.70

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

127

1.42

0.70

1.1

1.0

—

Other maternal disorders predominantly related to pregnancy

0.58

0.70

1.0

—

126

0.62

0.70

1.0

—

Mental and behavioural disorders due to psychoactive substance use

130

0.63

0.69

1.0

—

Other inflammation of eyelid

1.85

0.68

1.0

—

Diaphragmatic hernia

1.53

0.68

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

107

1.44

0.68

1.0

—

Dizziness and giddiness

118

1.38

0.67

1.0

—

Statin medication

109

0.67

1.0

—

Diseases of the eye and adnexa

101

1.34

0.66

1.0

—

Postmenopausal bleeding

1.74

0.65

1.0

—

Psychiatric diseases

120

0.71

0.65

1.0

—

Peritonsillar abscess

1.59

0.65

1.0

—

Diseases of salivary glands

1.61

0.65

1.0

—

Other menopausal disorders

1.71

0.64

1.0

—

Other neurological diseases

102

0.61

0.64

1.0

—

Gout, unspecified

1.72

0.64

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

1.72

0.63

1.2

1.0

—

Allergic conjunctivitis

125

0.62

0.63

1.0

—

Cholecystectomy

109

1.40

0.63

1.0

—

Heart failure,strict

1.51

0.63

1.0

—

Acute appendicitis, no complications

129

1.39

0.61

1.1

1.0

—

Systemic connective tissue disorders

1.60

0.61

1.0

—

Excessive, frequent and irregular menstruation

1.58

0.61

1.1

1.0

—

Dental operations

1.52

0.61

1.0

—

Chalazion

0.00

0.60

0.0

1.0

—

Methotrexate

0.00

0.60

0.0

1.0

—

Lichen planus

0.00

0.60

0.0

1.0

—

Other disorders of amniotic fluid and membranes

0.00

0.59

0.0

1.0

—

Internal derangement of knee

1.53

0.59

1.0

—

Autoimmune diseases

127

1.28

0.59

1.0

—

Familial hypercholesterolemia

0.00

0.59

0.0

1.0

—

Unspecified lump in breast

0.00

0.59

0.0

1.0

—

Embedded and impacted teeth

1.51

0.58

1.0

—

In situ neoplasms

1.51

0.58

1.0

—

Osteoporosis

1.72

0.58

1.0

—

Leiomyoma of uterus

1.42

0.58

1.1

1.0

—

Other and unspecified urticaria

1.71

0.57

1.0

—

Seborrhoeic keratosis

1.71

0.57

1.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

1.71

0.57

1.2

1.0

—

Disorders of conjunctiva

152

0.71

0.56

1.0

—

Injuries to the thorax

0.55

1.0

—

Migraine

0.63

0.55

1.0

—

Care involving use of rehabilitation procedures

112

0.64

0.54

1.0

—

Bleeding

123

1.31

0.54

1.0

—

Substance abuse, excluding more controls

106

0.63

0.54

1.0

—

Mental and behavioural disorders due to alcohol

118

0.65

0.54

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

119

0.64

0.54

1.0

—

Diseases of the digestive system

1.50

0.54

1.0

—

Other benign neoplasms of skin

1.50

0.54

1.0

—

Urticaria

1.50

0.54

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

115

1.31

0.54

1.0

—

Reimbursement for rheumatic diseases

107

1.39

0.53

1.0

—

Stroke, excluding SAH

0.61

0.53

1.0

—

Coronary atherosclerosis

0.65

0.53

1.0

—

Diseases of oesophagus, stomach and duodenum

141

1.26

0.52

1.0

—

121

0.66

0.51

1.0

—

Symptoms and signs involving the urinary system

114

1.32

0.51

1.0

—

Tinnitus

1.50

0.51

1.0

—

All-cause Heart Failure

1.43

0.51

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.33

0.50

1.1

1.0

—

Fracture at wrist and hand level

1.46

0.50

1.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.57

0.50

1.0

—

Angina pectoris

0.63

0.49

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

143

1.26

0.49

1.0

—

Female infertility

1.55

0.49

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

137

0.76

0.49

1.0

—

Sleep apnoea, including avohilmo

143

0.76

0.49

1.0

—

Other and unspecified iron deficiency

1.55

0.48

1.1

1.0

—

Keratitis

1.45

0.48

1.0

—

Heart failure, strict

1.41

0.48

1.0

—

Disorders of sclera, cornea, iris and ciliary body

111

1.35

0.46

1.0

—

Nutritional anaemias

1.44

0.46

1.1

1.0

—

Fracture of foot, except ankle

1.43

0.46

1.0

—

Other anxiety disorders

1.37

0.45

1.0

—

STROKE

0.70

0.45

1.0

—

Striking against or struck by other objects

0.61

0.45

1.0

—

Vasomotor and allergic rhinitis

0.60

0.45

1.0

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.38

0.45

1.0

—

Type 2 diabetes, strict (exclude DM1)

135

0.78

0.44

1.0

—

Depression

146

1.24

0.43

1.0

—

Benign neoplasm: Sigmoid colon

1.61

0.43

1.0

—

Other chronic obstructive pulmonary disease, including avohilmo

0.65

0.42

1.0

—

Chronic sinusitis

1.41

0.42

1.0

—

Insulin medication

108

1.31

0.42

1.0

—

Exposure to unspecified factor

164

0.79

0.42

1.0

—

Type 2 diabetes, definitions combined

134

0.78

0.42

1.0

—

Diseases of liver

1.43

0.41

1.0

—

Cardiac arrhythmias

1.30

0.41

1.0

—

Gout, idiopatic and unspecified

1.52

0.41

1.0

—

Dysphagia

1.52

0.41

1.0

—

Other obstructed labour

0.00

0.41

0.0

1.0

—

Viral hepatitis, including avohilmo

0.00

0.41

0.0

1.0

—

Presbyopia

0.00

0.41

0.0

1.0

—

Sicca syndrome [Sjögren]

0.00

0.41

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

0.00

0.41

0.0

1.0

—

Other and unspecified rosacea

0.00

0.41

0.0

1.0

—

Myocardial infarction, unclassifiable

0.00

0.41

0.0

1.0

—

Heterophoria

0.00

0.41

0.0

1.0

—

Non-allergic asthma

0.00

0.41

0.0

1.0

—

Unspecified privation

0.00

0.41

0.0

1.0

—

Hypotension

0.00

0.41

0.0

1.0

—

Hypothyroidism, other/unspecified

115

1.26

0.41

1.0

—

Other endocrine disorders

0.00

0.41

0.0

1.0

—

Other CVD (FINNGEN)

0.00

0.40

0.0

1.0

—

Mood [affective] disorders

147

1.22

0.40

1.0

—

Carcinoma in situ of breast, intraductal

0.00

0.40

0.0

1.0

—

Other appendicitis

0.00

0.40

0.0

1.0

—

Disorder of lipoprotein metabolism, unspecified

0.00

0.40

0.0

1.0

—

Car occupant injured in other and unspecified transport accidents

1.47

0.40

1.0

—

Mood disorders

147

1.22

0.40

1.0

—

Infections of genitourinary tract in pregnancy

0.00

0.40

0.0

1.0

—

Diseases of the myoneural junction and muscle

0.00

0.40

0.0

1.0

—

Poor fetal growth

0.00

0.40

0.0

1.0

—

Dorsalgia

112

1.23

0.39

1.0

—

Diabetes medication

146

0.80

0.39

1.0

—

Hyperlipidaemia, other/unspecified

1.37

0.38

1.0

—

Other disorders of patella

1.39

0.38

1.0

—

Gingivitis and periodontal diseases

105

1.23

0.38

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

137

1.22

0.37

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.71

0.37

1.0

—

Injuries to the knee and lower leg

152

0.82

0.37

1.0

—

Hyperplasia of prostate

1.30

0.37

1.0

—

Non-selective monoamine reuptake inhibitors

1.31

0.37

1.0

—

Acute and subacute iridocyclitis

1.35

0.37

1.0

—

Persistent mood disorders

1.35

0.37

1.0

—

Other systemic involvement of connective tissue

1.35

0.37

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

116

1.21

0.37

1.0

—

Iron deficiency anaemia

1.30

0.37

1.1

1.0

—

Inflammatory bowel disease

1.39

0.36

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

140

0.80

0.36

1.0

—

Female infertility, cervical, vaginal, other or unspecified origin

1.42

0.36

1.0

—

Senile cataract

1.28

0.35

1.0

—

Asthma/COPD (KELA code 203)

144

1.21

0.35

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.43

0.35

1.0

—

Fissure and fistula of anal and rectal regions

1.43

0.35

1.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.41

0.35

1.0

—

Sleep apnoea

141

0.80

0.35

1.0

—

Complications predominantly related to the puerperium

1.40

0.35

1.0

—

Conjunctivitis

144

0.78

0.35

1.0

—

Postmenopausal atrophic vaginitis

1.36

0.34

1.0

—

IBD patients in KELA-register

1.36

0.34

1.0

—

Continuous positive airway pressure

1.35

0.34

1.0

—

Other retinal disorders

1.30

0.34

1.1

1.0

—

Early onset COPD

1.33

0.33

1.0

—

Non-rheumatic valve diseases

0.67

0.33

1.0

—

Polycystic ovarian syndrome, consortium definition

1.27

0.33

1.1

1.0

—

Valvular heart disease excluding rheumatic fever

0.66

0.33

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.68

0.33

1.0

—

Fall on same level involving ice and snow

118

1.27

0.33

1.1

1.0

—

Cardiodefibrillation

1.30

0.33

1.0

—

Low back pain

110

1.23

0.32

1.0

—

Functional dyspepsia

1.28

0.32

1.0

—

Disturbances of skin sensation

1.28

0.32

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

144

0.83

0.31

1.0

—

Viral and other specified intestinal infections, including avohilmo

1.35

0.31

1.0

—

Benign lipomatous neoplasm

1.35

0.31

1.0

—

Primary gonarthrosis, bilateral

0.72

0.31

1.0

—

Other cataract

1.35

0.31

1.1

1.0

—

Diseases of the musculoskeletal system and connective tissue

1.27

0.31

1.0

—

Irregular menses

1.31

0.31

1.1

1.0

—

Cutaneous abscess, furuncle and carbuncle

1.32

0.30

1.0

—

Atrial fibrillation and flutter

1.29

0.30

1.0

—

Triptan medication for migraine, min. 3 purchases

0.76

0.30

1.0

—

Artificial joint operation, meniscal resection

126

0.81

0.30

1.0

—

Anxiety (asthma-related co-morbidities)

116

0.79

0.29

1.0

—

Mood disorders, excluding more controls

124

1.18

0.29

1.0

—

Strabismus

1.25

0.29

1.0

—

Open wound of wrist and hand

105

0.74

0.29

1.1

1.0

—

Varicose veins

1.27

0.29

1.0

—

Other and unspecified effects of external causes

1.23

0.29

1.0

—

Missing teeth due to accident, extraction or parodontitis

108

1.24

0.28

1.0

—

Injuries to the ankle and foot

143

1.19

0.27

1.0

—

Other abnormal products of conception

0.68

0.26

1.0

—

Gastro-oesophageal reflux disease

126

1.20

0.26

1.0

—

Injuries to the shoulder and upper arm

149

0.83

0.26

1.0

—

Transient ischemic attack

0.66

0.26

1.0

—

Type 2 diabetes

137

0.84

0.26

1.0

—

Cervical disc disorders

0.70

0.26

1.2

1.0

—

Injury of muscle and tendon at shoulder and upper arm level

0.69

0.26

1.0

—

Obesity related asthma

0.68

0.26

1.0

—

Cough

1.30

0.25

1.0

—

Arthropathies

1.17

0.25

1.0

—

Pregnancy hypertension

0.73

0.24

1.0

—

Other functional intestinal disorders

0.73

0.24

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

110

0.83

0.24

1.0

—

Other dorsopathies, not elsewhere classified

112

1.16

0.24

1.0

—

Dorsopathies

114

1.15

0.23

1.0

—

Other external causes of accidental injury

1.17

0.23

1.0

—

5-aminosalicylic acid

1.32

0.23

1.0

—

Primary coxarthrosis, bilateral

1.32

0.23

1.0

—

Rotator cuff syndrome

0.81

0.23

1.0

—

Anterior Iridocyclitis

1.28

0.23

1.0

—

Acne, including avohilmo

1.26

0.22

1.0

—

Visual disturbances and blindness

0.75

0.22

1.0

—

L02BG Aromatase inhibitors

1.23

0.22

1.0

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

0.22

0.0

1.0

—

Iridocyclitis

1.22

0.22

1.0

—

Adverse effects, not elsewhere classified

1.22

0.22

1.0

—

Later onset COPD, excluding more controls

0.00

0.21

0.0

1.0

—

Pain in joint

0.76

0.21

1.0

—

Short stature, not elsewhere classified

0.00

0.21

0.0

1.0

—

Injuries to the neck

1.19

0.21

1.0

—

Atrial septal defect

0.00

0.21

0.0

1.0

—

Atrial septal defect, secundum type

0.00

0.21

0.0

1.0

—

Congenital malformations of aortic and mitral valves

0.00

0.21

0.0

1.0

—

Amblyopia ex anopsia

0.00

0.21

0.0

1.0

—

Pustulosis palmaris et plantaris

0.00

0.21

0.0

1.0

—

Gluteal tendinitis

0.00

0.21

0.0

1.0

—

Left ventricular outflow tract obstruction, narrow definition

0.00

0.21

0.0

1.0

—

Pustular psoriasis

0.00

0.21

0.0

1.0

—

Anorexia (incl.atypical)

0.00

0.21

0.0

1.0

—

Labour and delivery complicated by umbilical cord complications

0.00

0.21

0.0

1.0

—

Abnormal blood-pressure reading, without diagnosis

0.00

0.21

0.0

1.0

—

Other specified/unspecified inflammatory spondylopathies

0.00

0.21

0.0

1.0

—

Chronic viral hepatitis

0.00

0.21

0.0

1.0

—

Other specified/unspecified systemic involvement of connective tissue

0.00

0.21

0.0

1.0

—

Lesion of plantar nerve

0.00

0.21

0.0

1.0

—

Recurrent dislocation of patella

0.00

0.21

0.0

1.0

—

Chronic suppurative otitis media

0.00

0.21

0.0

1.0

—

Trigeminal neuralgia

0.00

0.21

0.0

1.0

—

Cerebral cysts

0.00

0.21

0.0

1.0

—

Radial styloid tenosynovitis [de Quervain]

0.00

0.21

0.0

1.0

—

Pediculosis, acariasis and other infestations

0.00

0.21

0.0

1.0

—

Obsessive-compulsive disorder

0.00

0.21

0.0

1.0

—

Hordeolum and other deep inflammation of eyelid

0.00

0.21

0.0

1.0

—

Ulcerative proctitis

0.00

0.21

0.0

1.0

—

Focal brain injury

0.00

0.21

0.0

1.0

—

Astigmatism

0.00

0.21

0.0

1.0

—

Autoimmune hyperthyroidism

0.00

0.21

0.0

1.0

—

Alcohol withdrawal state with delirium

0.00

0.21

0.0

1.0

—

Postprocedural musculoskeletal disorders, not elsewhere classified

0.00

0.21

0.0

1.0

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

0.21

0.0

1.0

—

Thyroiditis

0.00

0.21

0.0

1.0

—

Vasomotor rhinitis (mode)

0.00

0.21

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

0.00

0.21

0.0

1.0

—

Invasive ventilation

0.00

0.21

0.0

1.0

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.21

0.0

1.0

—

Benign neoplasm: Parotid gland

0.00

0.21

0.0

1.0

—

Persistent delusional disorders

0.00

0.21

0.0

1.0

—

Other and unspecified injuries of head

0.00

0.21

0.0

1.0

—

Endometriosis of rectovaginal septum and vagina

0.00

0.21

0.0

1.0

—

Other peripheral vascular diseases

0.00

0.21

0.0

1.0

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

0.21

0.0

1.0

—

Benign neoplasm: salivary glands, exclude unknown (D119)

0.00

0.21

0.0

1.0

—

Visual field defects

0.00

0.21

0.0

1.0

—

Assault by bodily force

0.00

0.21

0.0

1.0

—

Transient global amnesia

0.00

0.21

0.0

1.0

—

Neuromuscular dysfunction of bladder

0.00

0.21

0.0

1.0

—

Other diseases of arteries and capillaries

0.00

0.21

0.0

1.0

—

Abnormal findings on antenatal screening of mother

0.00

0.21

0.0

1.0

—

Disorders of speech understanding and production

0.00

0.21

0.0

1.0

—

Colon adenocarcinoma, helper endpoint

0.00

0.21

0.0

1.0

—

Alzheimer’s disease, strict definition

0.00

0.21

0.0

1.0

—

Diseases of pulp and periapical tissues and dental caries

1.22

0.21

1.0

—

Artrosis, including avohilmo

104

1.16

0.21

1.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

0.21

0.0

1.0

—

Dermatographic urticaria

0.00

0.21

0.0

1.0

—

conjunctival haemorrhage

0.00

0.21

0.0

1.0

—

Schizoaffective disorder

0.00

0.21

0.0

1.0

—

Other and unspecified injuries of lower leg

0.00

0.21

0.0

1.0

—

Unspecified urinary incontinence

0.00

0.21

0.0

1.0

—

Amiodarone users

0.00

0.21

0.0

1.0

—

Other diseases of biliary tract

0.00

0.21

0.0

1.0

—

Subarachnoid haemorrhage

0.00

0.21

0.0

1.0

—

Polyp of the female genital tract

1.31

0.21

1.2

1.0

—

Emotional disorders starting during childhood or adolescence

0.00

0.21

0.0

1.0

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

0.21

0.0

1.0

—

Unspecified fall

100

0.78

0.21

1.0

—

Periapical abscess

105

0.76

0.21

1.0

—

Soft tissue disorders

124

0.87

0.21

1.0

—

Use of memantine

0.00

0.21

0.0

1.0

—

Use of other anti-dementia drugs

0.00

0.21

0.0

1.0

—

Unspecified abortion

0.00

0.21

0.0

1.1

—

Olecranon bursitis

0.00

0.21

0.0

1.0

—

Other viral hepatitis

0.00

0.21

0.0

1.0

—

L04AC Interleukin inhibitors

0.00

0.21

0.0

1.0

—

Other viral hepatitis, including avohilmo

0.00

0.21

0.0

1.0

—

Fibrosis and cirrhosis of liver

0.00

0.21

0.0

1.0

—

Ascites

0.00

0.21

0.0

1.0

—

Other and unspecified mood [affective] disorders

0.00

0.21

0.0

1.0

—

Chronic suppurative otitis media, including avohilmo

0.00

0.21

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

0.00

0.21

0.0

1.0

—

Ménière disease

0.00

0.21

0.0

1.0

—

Deep endometriosis

0.00

0.21

0.0

1.0

—

Benign neoplasm of major salivary glands

0.00

0.21

0.0

1.0

—

Faecal incontinence

0.00

0.21

0.0

1.0

—

Recurrent dislocation and subluxation of joint

0.00

0.21

0.0

1.0

—

Other sexually transmitted chlamydial diseases, including avohilmo

0.00

0.21

0.0

1.0

—

Other congenital malformations of the digestive system

0.00

0.20

0.0

1.0

—

Pregnancy with abortive outcome

0.77

0.20

1.0

—

Unspecified/other endometriosis

0.00

0.20

0.0

1.0

—

Nontoxic single thyroid nodule

0.00

0.20

0.0

1.0

—

Viral hepatitis

0.00

0.20

0.0

1.0

—

Mixed and other personality disorders

0.00

0.20

0.0

1.0

—

0.00

0.20

0.0

1.0

—

Other peripheral vertigo

0.00

0.20

0.0

1.0

—

Embedded teeth, including avohilmo

0.00

0.20

0.0

1.0

—

Postpartum haemorrhage due to anatomy

0.00

0.20

0.0

1.0

—

Colonic or urogenital fistula

1.25

0.20

1.0

—

Other congenital malformations of the digestive system, including avohilmo

0.00

0.20

0.0

1.0

—

Conduction disorders

1.23

0.20

1.0

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.20

0.0

1.0

—

Inflammatory bowel disease, strict (require KELA)

1.22

0.20

1.0

—

Irritable bowel syndrome

1.22

0.20

1.0

—

Hypoplasia of dental enamel , including avohilmo

0.00

0.20

0.0

1.0

—

Other diseases of the digestive system

1.22

0.20

1.0

—

GI-bleeding

1.22

0.20

1.0

—

Disorders of skin appendages

111

0.81

0.20

1.0

—

Molar incisor enamel hypoplasia

0.00

0.20

0.0

1.0

—

Other joint disorders

0.85

0.20

1.1

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

115

0.78

0.20

1.0

—

Intestinal stricture

1.20

0.19

1.0

—

Haemorrhoids and perianal venous thrombosis

1.19

0.19

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.19

0.19

1.0

—

Cerebrovascular diseases

100

0.83

0.19

1.0

—

Other specified/unspecified arthritis

1.18

0.19

1.0

—

Rheumatoid arthritis

1.15

0.19

1.0

—

Other intervertebral disc disorders

105

0.85

0.19

1.0

—

Tonsillectomy and adenotomy

100

0.83

0.19

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

1.13

0.18

1.0

—

Conjunctivitis (acute, non atopic), including avohilmo

145

1.12

0.18

1.0

—

Other arthritis (FG)

1.21

0.18

1.0

—

Degeneration of macula and posterior pole

1.17

0.18

1.1

1.0

—

Dyspnoea

140

1.13

0.17

1.0

—

Medicines for HER+ breast cancer

1.14

0.17

1.0

—

Diabetes mellitus in pregnancy

0.71

0.17

1.0

—

Deviated nasal septum

1.11

0.17

1.0

—

Atopic dermatitis, strict definition

0.76

0.17

1.0

—

Disorders of refraction and accommodation

0.75

0.17

1.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

0.74

0.17

1.0

—

Schizophrenia, schizotypal and delusional disorders

0.74

0.17

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

0.74

0.17

1.0

—

Other enthesopathies

0.73

0.17

1.0

—

Chronic periodontitis, complicated

117

0.83

0.16

1.0

—

Insulin, fast-acting

1.14

0.16

1.0

—

Insulin, fast-acting or short human

1.11

0.16

1.0

—

Other disorders of veins

1.11

0.16

1.0

—

Suppurative and unspecified otitis media

0.79

0.15

1.0

—

Arthrosis

1.15

0.15

1.0

—

Papulosquamous disorders

0.77

0.15

1.0

—

Lumbar disc prolapse

104

0.85

0.15

1.0

—

Other diseases of urinary system

132

0.89

0.15

1.0

—

Neurological diseases

108

1.12

0.15

1.0

—

Spontaneous abortion

0.81

0.15

1.0

—

Glaucoma

0.81

0.14

1.0

—

Visual disturbances

0.79

0.14

1.0

—

Acute appendicitis

148

1.13

0.14

1.1

1.0

—

Spinal stenosis

0.80

0.14

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

103

1.15

0.13

1.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.85

0.13

1.0

—

Diseases of arteries, arterioles and capillaries

0.86

0.13

1.0

—

Other arthrosis

0.83

0.13

1.0

—

Episodal and paroxysmal disorders

134

0.91

0.13

1.0

—

Shoulder lesions

102

0.88

0.13

1.0

—

Gonarthrosis [arthrosis of knee](FG)

1.13

0.13

1.0

—

Dental caries, including avohilmo

1.14

0.13

1.0

—

Pure hypercholesterolaemia

101

0.88

0.12

1.0

—

Injuries to the elbow and forearm

130

1.12

0.12

1.0

—

Dermatophytosis, including avohilmo

134

0.88

0.11

1.0

—

Diseases of inner ear

1.17

0.11

1.0

—

Cystitis

106

0.90

0.11

1.0

—

Lower back pain or/and sciatica

149

1.08

0.10

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

109

1.09

0.10

1.0

—

Uterine polyps

1.12

0.10

1.2

1.0

—

Superficial injury of head

1.13

0.10

1.0

—

Falls/tendency to fall

135

1.08

0.10

1.0

—

Ulcerative colitis

1.11

0.09

1.0

—

Cervicobrachial syndrome

1.11

0.09

1.0

—

Supervision of high-risk pregnancy

1.07

0.09

1.0

1.1

—

Voice disturbances

1.09

0.09

1.0

—

Fall on and from stairs and steps

1.09

0.09

1.0

—

COPD, hospital admission 2, with asthma infections

1.05

0.09

1.0

—

Constipation

140

0.92

0.09

1.0

—

COPD related to multimorbidity

1.10

0.09

1.0

—

Retinal detachments and breaks

1.11

0.09

1.2

1.0

—

Cerebrovascular diseases (FINNGEN)

1.08

0.09

1.0

—

Long labour

1.08

0.09

1.0

—

Psoriasis

1.07

0.08

1.0

—

Atopic dermatitis, strict definition with reimbursement

1.07

0.08

1.0

—

Acute suppurative otitis media

1.05

0.08

1.0

—

Infections with a predominantly sexual mode of transmission

1.03

0.08

1.0

—

Fall on same level

150

1.07

0.08

1.0

—

Disorders of synovium and tendon

1.11

0.08

1.0

—

Conjunctivitis (acute, non atopic)

1.09

0.08

1.0

—

Other and unspecified tonsillitis

1.06

0.08

1.0

—

Heart failure and bmi 25plus

1.04

0.08

1.0

—

Gestational diabetes (for exclusion)

0.83

0.08

1.0

—

COPD

0.83

0.07

1.0

—

Other disorders of eyelid

1.02

0.07

1.0

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.83

0.07

1.0

—

Atopic dermatitis

106

0.90

0.07

1.0

—

Obesity, other/unspecified

0.81

0.07

1.0

—

Abrasion of teeth

0.80

0.07

1.0

—

Other arrhythmias

102

1.10

0.07

1.0

—

Other symptoms and signs involving cognitive functions and awareness

1.03

0.07

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

111

0.89

0.07

1.0

—

Persons with potential health hazards related to communicable diseases

0.85

0.07

1.0

—

Infections with a predominantly sexual mode of transmission, including avohilmo

0.82

0.07

1.0

—

Disorders of vitreous body

0.88

0.06

1.1

1.0

—

Disorders of vitreous body and globe

0.87

0.06

1.1

1.0

—

Temporomandibular joint disorders, including avohilmo

0.84

0.06

1.0

—

1.11

0.06

1.0

—

Other antidepressants

115

1.06

0.06

1.0

—

Meniscus derangement

0.90

0.06

1.0

—

Diseases of middle ear and mastoid

1.09

0.06

1.0

—

Cholelithiasis, broad definition with cholecystitis

118

1.07

0.06

1.1

1.0

—

Spondylopathies

1.07

0.05

1.0

—

Type 2 diabetes, wide definition

118

1.07

0.05

1.0

—

Inguinal hernia

0.92

0.05

1.0

—

Cholelithiasis

115

1.07

0.05

1.1

1.0

—

Carpal tunnel syndrome

104

1.08

0.04

1.0

—

Appendicitis, broad definition

152

1.06

0.04

1.1

1.0

—

Periodontitis

141

0.95

0.04

1.0

—

Gonarthrosis,primary

115

0.94

0.04

1.0

—

Chronic periodontitis, including avohilmo

141

0.95

0.04

1.0

—

Diverticular disease of intestine

0.93

0.04

1.0

—

Diabetes mellitus

145

0.96

0.04

1.0

—

Diseases of appendix

152

1.06

0.04

1.1

1.0

—

Medical abortion

0.92

0.03

1.0

—

Concussion

1.07

0.03

1.0

—

Diabetes, varying definitions

145

0.96

0.03

1.0

—

Intracranial injury

114

1.06

0.02

1.0

—

Obesity and other hyperalimentation

129

0.95

0.02

1.0

—

Obesity due to excess calories

107

0.93

0.02

1.0

—

Obesity

129

0.95

0.01

1.0

—

Transport accidents

0.93

0.01

1.0

—

Dislocation, sprain and strain of joints and ligaments of knee

142

0.95

0.01

1.0

—

Pain in throat and chest

111

0.96

0.01

1.0

—

Appendectomy

136

1.05

0.01

1.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

103

1.06

0.01

1.0

—

All anxiety disorders

114

0.95

0.01

1.0

—

Triptan medication for migraine, single purchase ok

126

0.97

0.00

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

126

0.97

0.00

1.0

—

Insulin, intermediate and long-acting

101

1.05

0.00

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

107

0.99

0.00

1.0

—

Sciatica+with lumbago

1.01

0.00

1.0

—

Other disorders of urethra and urinary system

102

1.02

0.00

1.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.05

0.00

1.0

—

Accidents

1.01

0.00

1.1

1.0

—

Caries of dentine, including avohilmo

1.01

0.00

1.0

—

Disorders of choroid and retina

117

1.02

0.00

1.1

1.0

—

Intracranial trauma

1.01

0.00

1.0

—

Selective serotonin reuptake inhibitors

117

0.98

0.00

1.0

—

Fracture of forearm

100

0.99

0.00

1.0

—

Any mental disorder

127

0.99

0.00

1.0

—

Urinary track infection

0.97

0.00

1.0

—

Excessive attrition of teeth

138

1.00

0.00

1.0

—

Gonarthrosis, primary, with knee surgery

1.03

0.00

1.0

—

Injuries to the wrist and hand

153

1.00

0.00

1.0

—

Dentofacial anomalies [including malocclusion]

133

1.00

0.00

1.0

—

Hernia

143

0.98

0.00

1.0

—

Asthma, including avohilmo

153

1.01

0.00

1.0

—

Gonarthrosis

0.98

0.00

1.0

—

Spondylosis

0.97

0.00

1.0

—

Necrosis of pulp, including avohilmo

137

1.01

0.00

1.0

—

Benign neoplasm: Colon

1.04

0.00

1.0

—

Other specific joint derangements/joint disorders

1.03

0.00

1.0

—

Other nutritional deficiencies

134

1.02

0.00

1.0

—

Inflammatory diseases of female pelvic organs

0.98

0.00

1.0

—

Recurrent or chronic depression

0.99

0.00

1.0

—

Disorders of the thyroid gland

128

1.01

0.00

1.1

1.0

—

Other congenital malformations of heart

0.00

0.0

1.0

—

Symptoms and signs involving speech and voice

0.88

0.00

1.0

—

Other spirochaetal diseases

0.90

0.00

1.0

—

Dissection of aorta

0.00

0.0

1.0

—

Alzheimer’s disease (Late onset)

0.00

0.0

1.0

—

Other and unspecified mononeuropathies of lower limb

0.00

0.0

1.0

—

Other symptoms and signs involving general sensations and perceptions

0.00

0.0

1.0

—

Simple and mucopurulent chronic bronchitis

0.00

0.0

1.0

—

Hemiplegia

0.00

0.0

1.0

—

Effects of foreign body entering through natural orifice

0.88

0.00

1.0

—

Other and unspecified nail disorders

0.00

0.0

1.0

—

Visual impairment including blindness (binocular or monocular)

0.00

0.0

1.0

—

Struck by thrown, projected or falling objec

0.00

0.0

1.0

—

Ulcerative ileocolitis

0.00

0.0

1.0

—

Exposure to other and unspecified animate mechanical forces

0.00

0.0

1.0

—

Foreign body in alimentary tract

0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of head

0.00

0.0

1.0

—

Glaucoma, exfoliation

0.00

0.0

1.0

—

Contusion of ankle

0.00

0.0

1.0

—

Burn and corrosion of trunk

0.00

0.0

1.0

—

Adrenocortical insufficiency

0.00

0.0

1.0

—

Disturbances of smell and taste

0.00

0.0

1.0

—

Maxillary retrognathism

0.00

0.0

1.0

—

Muscle strain

0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.00

0.0

1.0

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.0

1.0

—

Right hemicolectomy

0.00

0.0

1.0

—

Polyhydramnios

0.00

0.0

1.0

—

Short Achilles tendon (acquired)

0.00

0.0

1.0

—

Iridocyclitis in diseases classified elsewhere

0.00

0.0

1.0

—

Normotensive glaucoma

0.00

0.0

1.0

—

Neuralgia and neuritis, unspecified

0.00

0.0

1.0

—

Golimumab

0.00

0.0

1.0

—

Other disorders of bone density and structure

0.00

0.0

1.0

—

Oesophageal varices

0.00

0.0

1.0

—

Emphysema

0.00

0.0

1.0

—

Other inflammation of vagina/vulva

0.00

0.0

1.0

—

Carcinoma in situ of colon

0.00

0.0

1.0

—

Cirrhosis of liver, NAS

0.00

0.0

1.0

—

Disorders of vestibular function (Vertigo)

0.93

0.00

1.0

—

Pathological resorption of teeth

0.00

0.0

1.0

—

Other and unspecified mononeuropathies, also in other diseases

0.00

0.0

1.0

—

Other and unspecified myopathies

0.00

0.0

1.0

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

0.0

1.0

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.0

1.0

—

Other specified and unspecified disorders of eye and adnexa

0.00

0.0

1.0

—

Arthropathies in other diseases classified elsewhere

0.00

0.0

1.0

—

Benign neoplasm of other and unspecified female genital organs

0.00

0.0

1.0

—

Other specified/unspecified dorsopathies

0.00

0.0

1.0

—

Chronic mastoiditis

0.00

0.0

1.0

—

Acute alcohol intoxication ICD-9

0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

1.0

—

Hypertrophic cardiomyopathy

0.00

-0.00

0.0

1.0

—

Contusion of other and unspecified parts of foot

0.00

-0.00

0.0

1.0

—

Delirium, not induced by alcohol and other psychoactive substances

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joint and ligaments of hip

0.00

-0.00

0.0

1.0

—

Lactose intolerance, other/unspecified

0.00

-0.00

0.0

1.0

—

Manic episode

0.00

-0.00

0.0

1.0

—

Unspecified dementia

0.00

-0.00

0.0

1.0

—

Lyme disease

0.91

-0.00

1.0

—

Extreme obesity with alveolar hypoventilation

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of neck and trunk

0.00

-0.00

0.0

1.0

—

Abdominal aortic aneurysm (AAA)

0.00

-0.00

0.0

1.0

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

0.00

-0.00

0.0

1.0

—

Dementia in Alzheimer disease

0.00

-0.00

0.0

1.0

—

Speech disturbances, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Superficial injuries involving multiple body regions

0.00

-0.00

0.0

1.0

—

SLE, ICD10

0.00

-0.00

0.0

1.0

—

Unknown and unspecified causes of morbidity

0.00

-0.00

0.0

1.0

—

Thyrotoxicosis with toxic multinodular goitre

0.00

-0.00

0.0

1.0

—

Cramp and spasm

0.00

-0.00

0.0

1.0

—

Subacute thyroiditis

0.00

-0.00

0.0

1.0

—

Pneumonitis due to solids and liquids

0.00

-0.00

0.0

1.0

—

Erectile dysfunction

0.00

-0.00

0.0

1.0

—

Burn and corrosion of wrist and hand

0.00

-0.00

0.0

1.0

—

Other vitreous opacities

0.00

-0.00

0.0

1.0

—

Injuries to the hip and thigh

0.92

-0.00

1.0

—

Other specified disorders of kidney and ureter

0.00

-0.00

0.0

1.0

—

Isolated patent ductus arteriosus

0.00

-0.00

0.0

1.0

—

Other disorders of adrenal gland

0.00

-0.00

0.0

1.0

—

Other secondary coxarthrosis

0.00

-0.00

0.0

1.0

—

Other and unspecified disorders of vitreous body

0.88

-0.00

1.0

—

Anti-inflammatory and antirheumatic products, non-steroids

0.97

-0.00

1.0

—

Vitamin B12 deficiency anaemia

0.00

-0.00

0.0

1.0

—

Benign neoplasm of brain and other parts of central nervous system

0.00

-0.00

0.0

1.0

—

Conotruncal defects

0.00

-0.00

0.0

1.0

—

Familial hypercholesterolemia, with ischemic heart disease

0.00

-0.00

0.0

1.0

—

Patent foramen ovale

0.00

-0.00

0.0

1.0

—

Benign neoplasm of middle ear and respiratory system

0.00

-0.00

0.0

1.0

—

Exclusion endpoint for clefts

0.00

-0.00

0.0

1.0

—

Hypoplasia of dental enamel

0.00

-0.00

0.0

1.0

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

1.0

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

-0.00

0.0

1.0

—

Iron deficiency

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.0

—

Use of biperiden

0.00

-0.00

0.0

1.0

—

Emotional disorders starting during childhood or adolecense, excluding more controls

0.00

-0.00

0.0

1.0

—

Monoarthritis, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Use of ropinirole

0.00

-0.00

0.0

1.0

—

Other specified disorders of muscle

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.00

-0.00

0.0

1.0

—

Chronic Coagulation defects

0.00

-0.00

0.0

1.0

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

-0.00

0.0

1.0

—

Sacroiliitis, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin of scalp and neck

0.00

-0.00

0.0

1.0

—

Bursitis of shoulder

0.00

-0.00

0.0

1.0

—

Other deformities of toe(s)

0.00

-0.00

0.0

1.0

—

Artificial joint re-operation

0.00

-0.00

0.0

1.0

—

Other chronic obstructive pulmonary disease

0.89

-0.00

1.0

—

LeFortI or BSSO operation

0.00

-0.00

0.0

1.0

—

Fracture of neck

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Conjunctiva

0.00

-0.00

0.0

1.0

—

Abscess of Bartholin gland

0.00

-0.00

0.0

1.0

—

Fracture of shoulder and upper arm

0.87

-0.00

1.0

—

Other and unspecified disease of Bartholin gland

0.00

-0.00

0.0

1.0

—

Injuries involving multiple body regions

0.00

-0.00

0.0

1.0

—

Bilateral sagittal split ramus osteotomy operation

0.00

-0.00

0.0

1.0

—

Complications following abortion and ectopic and molar pregnancy

0.00

-0.00

0.0

1.0

—

Neurological diseases, wide definition

1.00

-0.00

1.0

—

Inflammatory disorders of breast

0.00

-0.00

0.0

1.0

—

Inflammatory disease of cervix uteri

0.00

-0.00

0.0

1.0

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.00

-0.00

0.0

1.0

—

Cyst of Bartholin Gland

0.00

-0.00

0.0

1.0

—

Enteropathic arthropathies

0.00

-0.00

0.0

1.0

—

Rheumatoid arthritis, including avohilmo

1.00

-0.00

1.0

—

Impotence

0.00

-0.00

0.0

1.0

—

Disorders of synovium and tendon in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Hyperaldosteronism

0.00

-0.00

0.0

1.0

—

Primary angle-closure glaucoma

0.00

-0.00

0.0

1.0

—

Mixed hyperlipidaemia

0.00

-0.00

0.0

1.0

—

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

0.00

-0.00

0.0

1.0

—

Chondrocostal junction syndrome [Tietze]

0.00

-0.00

0.0

1.0

—

Other specified/unspecified soft tissue disorders

0.00

-0.00

0.0

1.0

—

Hereditary corneal dystrophies

0.00

-0.00

0.0

1.0

—

Idiopathic pulmonary fibrosis

0.00

-0.00

0.0

1.0

—

Myositis

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Early onset)

0.00

-0.00

0.0

1.0

—

Presbycusis

0.00

-0.00

0.0

1.0

—

Infective bursitis

0.00

-0.00

0.0

1.0

—

Tuberculosis

0.00

-0.00

0.0

1.0

—

Other disorders of Eustachian tube

0.00

-0.00

0.0

1.0

—

Inguinal hernia, unilateral

0.00

-0.00

0.0

1.0

—

Spirochaetal infections, other/unspecified, including avohilmo

0.90

-0.00

1.0

—

Polycystic kidney disease

0.00

-0.00

0.0

1.0

—

Erosion and ectropion of cervix uteri

0.00

-0.00

0.0

1.0

—

Other neurotic disorders

0.00

-0.00

0.0

1.0

—

Biological medicines for asthma

0.00

-0.00

0.0

1.0

—

Biomechanical lesions, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.00

-0.00

1.0

—

Sacrococcygeal disorders, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Barrett oesophagus

0.00

-0.00

0.0

1.0

—

Chronic hepatitis, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Lichen simplex chronicus

0.00

-0.00

0.0

1.0

—

Anisometropia and aniseikonia

0.00

-0.00

0.0

1.0

—

Perioral dermatitis

0.00

-0.00

0.0

1.0

—

Cholesteatoma of middle ear

0.00

-0.00

0.0

1.0

—

Other strabismus

1.02

-0.00

1.0

—

L02BB Anti-androgens

0.00

-0.00

0.0

1.0

—

Femoral hernia

0.00

-0.00

0.0

1.0

—

Other erythematous conditions

0.00

-0.00

0.0

1.0

—

Aggressive periodontitis

0.00

-0.00

0.0

1.0

—

Juvenile osteochondrosis

0.00

-0.00

0.0

1.0

—

Loose body in joint

0.00

-0.00

0.0

1.0

—

SLE (Finngen)

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Other and unspecified parts of mouth

0.00

-0.00

0.0

1.0

—

Other disorders of pigmentation

0.00

-0.00

0.0

1.0

—

Other diseases of peritoneum

0.00

-0.00

0.0

1.0

—

Oesophagitis

0.00

-0.00

0.0

1.0

—

Respiratory tuberculosis

0.00

-0.00

0.0

1.0

—

Benign neoplasm of thyroid gland

0.00

-0.00

0.0

1.0

—

Benign neoplasm of urinary organs

0.00

-0.00

0.0

1.0

—

Viral hepatitis, IBD co-morbidity

0.00

-0.00

0.0

1.0

—

Hypoparathyroidism

0.00

-0.00

0.0

1.0

—

Crohn's disease of large intestine

0.00

-0.00

0.0

1.0

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

0.00

-0.00

0.0

1.0

—

Primary Sclerosing Cholangitis, IBD and UDCA required

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Early onset), excluding more controls

0.00

-0.00

0.0

1.0

—

Acute otitis externa, noninfective

0.00

-0.00

0.0

1.0

—

Epilepsy

0.91

-0.00

1.0

—

Alcohol-induced acute pancreatitis

0.00

-0.00

0.0

1.0

—

Sleep disorders, other/unspecified

0.00

-0.00

0.0

1.0

—

Bacterial meningitis

0.00

-0.00

0.0

1.0

—

Other otitis externa (chronic)

0.00

-0.00

0.0

1.0

—

Hydrocephalus

0.00

-0.00

0.0

1.0

—

Coarctation of the aorta

0.00

-0.00

0.0

1.0

—

Schizophrenia or delusion

0.88

-0.00

1.0

—

Systemic lupus erythematosus

0.00

-0.00

0.0

1.0

—

Status epilepticus

0.00

-0.00

0.0

1.0

—

Cysts of oral region, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

0.00

-0.00

0.0

1.0

—

Acute gastritis

0.00

-0.00

0.0

1.0

—

Intussusception

0.00

-0.00

0.0

1.0

—

Mandibular retrognathia AND surgery (BSSO)

0.00

-0.00

0.0

1.0

—

Psoriasis (vulgaris), strict definition

0.00

-0.00

0.0

1.0

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

0.00

-0.00

0.0

1.0

—

Bicuspidal aortic valve syndrome

0.00

-0.00

0.0

1.0

—

COPD, hospital admissions

0.90

-0.00

1.0

—

Congenital malformations of great arteries

0.00

-0.00

0.0

1.0

—

Other congenital malformations of tongue, mouth and pharynx

0.00

-0.00

0.0

1.0

—

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

0.00

-0.00

0.0

1.0

—

Use of rivastigmine

0.00

-0.00

0.0

1.0

—

Temporal arteritis

0.00

-0.00

0.0

1.0

—

Panniculitis affecting regions of neck and back

0.00

-0.00

0.0

1.0

—

Pyothorax

0.00

-0.00

0.0

1.0

—

Endocarditis

0.00

-0.00

0.0

1.0

—

Other acute skin changes due to ultraviolet radiation

0.00

-0.00

0.0

1.0

—

Behavioural disorders

0.00

-0.00

0.0

1.0

—

Secondary right heart disease

0.00

-0.00

0.0

1.0

—

Lyme disease, including avohilmo

0.91

-0.00

1.0

—

Maternal care for known or suspected disproportion

0.00

-0.00

0.0

1.0

—

Hernia of abdominal wall

1.00

-0.00

1.0

—

Respiratory tuberculosis, confirmed and not-confirmed

0.00

-0.00

0.0

1.0

—

Suppurative otitis media, unspecified

0.00

-0.00

0.0

1.0

—

Mixed disorders of conduct and emotions

0.00

-0.00

0.0

1.0

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.00

-0.00

0.0

1.0

—

Vertical strabismus

0.00

-0.00

0.0

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

0.94

-0.00

1.0

—

Herpesviral keratitis and keratoconjunctivitis

0.00

-0.00

0.0

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.00

-0.00

1.0

—

Maltreatment syndromes

0.00

-0.00

0.0

1.0

—

Scabies

0.00

-0.00

0.0

1.0

—

Other and unspecified iridocyclitis

0.00

-0.00

0.0

1.0

—

Glaucoma-related operations

0.00

-0.00

0.0

1.0

—

Other conjunctival vascular disorders and cysts

0.00

-0.00

0.0

1.0

—

Cluster headache, strict, including avohilmo

0.00

-0.00

0.0

1.0

—

Preterm labour and delivery

0.91

-0.00

1.0

—

Other and unspecified disorders of psychological development

0.00

-0.00

0.0

1.0

—

Osteoporosis with pathological fracture (FG)

0.00

-0.00

0.0

1.0

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

-0.00

0.0

1.0

—

Disorders in reading

0.00

-0.00

0.0

1.0

—

Inguinal of femoral hernia, unilateral

0.00

-0.00

0.0

1.0

—

Cluster headache, strict

0.00

-0.00

0.0

1.0

—

Anankastic personality disorder

0.00

-0.00

0.0

1.0

—

Femoral hernia, unilateral

0.00

-0.00

0.0

1.0

—

Cluster headache, wide

0.00

-0.00

0.0

1.0

—

Giant cell arteritis with polymyalgia rheumatica

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to opioids

0.00

-0.00

0.0

1.0

—

Other superficial mycoses

0.00

-0.00

0.0

1.0

—

Other spirochaetal diseases, including avohilmo

0.88

-0.00

1.0

—

Schizophrenia or delusion, excluding more controls

0.90

-0.00

1.0

—

Event of undetermined intent

0.00

-0.00

0.0

1.0

—

Systemic lupus erythematosus, unspecified

0.00

-0.00

0.0

1.0

—

Postmenopausal osteoporosis with pathological fracture

0.00

-0.00

0.0

1.0

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Lactose intolerance

0.00

-0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP)

0.00

-0.00

0.0

1.0

—

Birth asphyxia

0.00

-0.00

0.0

1.0

—

Pedestrian injured in collision with car, pick-up truck or van

0.00

-0.00

0.0

1.0

—

Fall involving bed

0.00

-0.00

0.0

1.0

—

Desensitization to allergens

0.00

-0.00

0.0

1.0

—

Unspecified event, undetermined intent

0.00

-0.00

0.0

1.0

—

Pedal cyclist injured in collision with motor vehicle

0.00

-0.00

0.0

1.0

—

Toxic effect of ethanol

0.00

-0.00

0.0

1.0

—

COPD, early/later onset

0.90

-0.00

1.0

—

Other maltreatment syndromes

0.00

-0.00

0.0

1.0

—

Caught, crushed, jammed or pinched in or between objects

0.00

-0.00

0.0

1.0

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

0.00

-0.00

0.0

1.0

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

-0.00

0.0

1.0

—

Preparatory care for dialysis

0.00

-0.00

0.0

1.0

—

Procedures for purposes other than remedying health state

0.00

-0.00

0.0

1.0

—

Foreign body or object entering through skin

0.00

-0.00

0.0

1.0

—

Disorders of breast

0.94

-0.00

1.0

—

Problems related to social environment

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Tongue

0.00

-0.00

0.0

1.0

—

Graves ophthalmopathy

0.00

-0.00

0.0

1.0

—

Follow-up care involving plastic surgery

0.00

-0.00

0.0

1.0

—

Mouth breathing

1.01

-0.00

1.0

—

Other and unspecified erythematous conditions

0.00

-0.00

0.0

1.0

—

Other pulmonary heart/vessel disease

0.00

-0.00

0.0

1.0

—

Erosion of teeth , including avohilmo

0.91

-0.00

1.0

—

Supervision of normal pregnancy

1.02

-0.00

1.0

1.1

—

Mild mental retardation

0.00

-0.00

0.0

1.0

—

Diabetic neuropathy

0.00

-0.00

0.0

1.0

—

Paralytic ileus

0.00

-0.00

0.0

1.0

—

Primary biliary cholangitis, wide definition

0.00

-0.00

0.0

1.0

—

Injury of nerves at wrist and hand level

0.00

-0.00

0.0

1.0

—

Umbilical hernia

0.97

-0.00

1.0

—

SLE, strict definition

0.00

-0.00

0.0

1.0

—

Hyperkinetic disorders (excl. ADHD)

0.00

-0.00

0.0

1.0

—

Injury of other and unspecified intrathoracic organs

0.00

-0.00

0.0

1.0

—

Other and unspecified glaucoma

0.00

-0.00

0.0

1.0

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

-0.00

0.0

1.0

—

Cluster headache, wide,, including avohilmo

0.00

-0.00

0.0

1.0

—

Hidradenitis suppurativa

0.00

-0.00

0.0

1.0

—

Ankyloglossia

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

HLA-B [Type] by High resolution

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS